2 Outstanding Dividend Stocks to Buy and Hold for a Decade
There is probably no dividend cut on the horizon for these healthcare companies.
In the current investing landscape, several trends are gaining traction, such as artificial intelligence (AI) and robotaxis. However, there is value in adhering to proven strategies for generating long-term returns above the average. One such approach involves investing in robust dividend-paying companies. Two such companies that merit renewed attention are Eli Lilly (NYSE:LLY) and Merck (NYSE:MRK).
Eli Lilly has been a standout growth stock within the pharmaceutical sector over the past five years. Its financial performance has been remarkable, primarily driven by its diabetes and weight loss products, Mounjaro and Zepbound. In the second quarter, Eli Lilly's revenue surged by 48% compared to the previous year, reaching $23 billion.
Moreover, its adjusted earnings per share rose by 33% year over year, reaching $8.38. The success of Mounjaro and Zepbound is expected to continue in the medium term, making Eli Lilly a compelling option for long-term investment.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
